Taysha Gene Therapies FY 2024 Earnings Preview Taysha Gene Therapies FY 2024 Earnings Preview Post ContenttshaRead More You might also be interested in reading Hyperfine GAAP EPS of -$0.12, revenue of $2.1M. February 25, 2025 In Mainstream ← Previous post Next post →